Arthur M. Cohen & Associates’s bluebird bio BLUE Stock Holding History

Arthur M. Cohen & Associates’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-124	Closed	-$205K	–	127
2019 Q2	$205K	Sell	124 -124	-50%	-$215K	0.07%	111
2019 Q1	$505K	Hold	248	–	–	0.18%	72
2018 Q4	$469	Hold	248	–	–	0.15%	75
2018 Q3	$469	Hold	248	–	–	0.14%	80
2018 Q2	$504K	Hold	248	–	–	0.19%	71
2018 Q1	$519K	Hold	248	–	–	0.2%	70
2017 Q4	$319	Buy	+248	New	+$503K	0.09%	90
2017 Q2	$338K	Buy	+248	New	+$299K	0.13%	82
2014 Q3	$441K	Buy	+248	New	+$114K	0.21%	76

Other funds holding BLUE

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Arthur M. Cohen & Associates's BLUE Position: Q3 2019 in Review

Arthur M. Cohen & Associates sold out of bluebird bio (BLUE) in Q3 2019, closing a stake of 124 shares — an estimated $205K sold.

Arthur M. Cohen & Associates first reported a position in BLUE in Q3 2014 and held it in 9 quarters. The position peaked at $519K in Q1 2018. 241 funds tracked by Wall St. Rank hold BLUE as of Q3 2019.

Arthur M. Cohen & Associates reported no remaining bluebird bio position as of Q3 2019 after selling out during the quarter.
Arthur M. Cohen & Associates sold 124 bluebird bio shares in Q3 2019, an estimated $205K.
Arthur M. Cohen & Associates first reported a position in bluebird bio in Q3 2014 and held it in 9 quarters.
Arthur M. Cohen & Associates's bluebird bio position peaked at $519K in Q1 2018.
241 funds tracked by Wall St. Rank held bluebird bio as of Q3 2019.

Based on Arthur M. Cohen & Associates's 13F filing for Q3 2019, filed 4 Nov 2019.